Biodesix (BDSX) Debt to Equity (2019 - 2025)
Biodesix's Debt to Equity history spans 7 years, with the latest figure at -$19.25 for Q4 2025.
- For Q4 2025, Debt to Equity fell 1203.63% year-over-year to -$19.25; the TTM value through Dec 2025 reached -$19.25, down 1203.63%, while the annual FY2025 figure was -$19.25, 1203.63% down from the prior year.
- Debt to Equity reached -$19.25 in Q4 2025 per BDSX's latest filing, up from -$27.36 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $41.11 in Q2 2025 to a low of -$30.61 in Q3 2023.
- Average Debt to Equity over 5 years is -$0.73, with a median of $1.45 recorded in 2021.
- Peak YoY movement for Debt to Equity: soared 4027.09% in 2021, then plummeted 2210.43% in 2025.
- A 5-year view of Debt to Equity shows it stood at $1.41 in 2021, then grew by 21.91% to $1.72 in 2022, then surged by 626.61% to $12.46 in 2023, then tumbled by 86.01% to $1.74 in 2024, then crashed by 1203.63% to -$19.25 in 2025.
- Per Business Quant, the three most recent readings for BDSX's Debt to Equity are -$19.25 (Q4 2025), -$27.36 (Q3 2025), and $41.11 (Q2 2025).